(R)-Mirtazapine

CAS: 61364-37-2

Ref. 3D-LCA36437

Informação sobre produto

• Nome: (R)-Mirtazapine
• Sinónimos: (-)-Mirtazapine, (14bR)-1,2,3,4,10,14b-Hexahydro-2-methylpyrazino[2,1-a]pyrido[2,3-c][2]benzazepine, (7R)-5-Methyl-2,5,19-triazatetracyclo[13.4.0.0[2,7].0[8,13]]nonadeca-1(19),8,10,12,15,17-hexaene, (R)-1,2,3,4,10,14b-Hexahydro-2-methylpyrazino(2,1-a)pyrido(2,3-c)(2)benzazepine, (R)-2-Methyl-1,2,3,4,10,14b-hexahydrobenzo[c]pyrazino[1,2-a]pyrido[3,2-f]azepine, (R)-6-Azamianserin, (R)-Org 3770, 262-735-5, Org 44-19, Pyrazino[2,1-a]pyrido[2,3-c][2]benzazepine, 1,2,3,4,10,14b-hexahydro-2-methyl-, (14bR)-, Pyrazino[2,1-a]pyrido[2,3-c][2]benzazepine, 1,2,3,4,10,14b-hexahydro-2-methyl-, (R)-

Descrição

(R)-Mirtazapine is the (S) enantiomer of mirtazapine, which is an antidepressant. It is a potent antagonist at presynaptic alpha-2 adrenergic receptors and postsynaptic 5HT2A receptors. The effective dose of (R)-mirtazapine ranges from 15 to 45 mg per day. Plasma concentrations are undetectable within 24 hours after taking a single dose of (R)-mirtazapine. Clinical pharmacology studies have shown that it increases serotonin levels in the brain by preventing its reuptake into the presynaptic neuron and by blocking serotonin degradation. The drug has been shown to be effective in various genetic types, including genotype 1 and 2 erythrocytes.

(R)-Mirtazapine is a scalable synthesis that prevents the reuptake of serotonin, which leads to increased levels of this neurotransmitter in the brain. This drug also has potent antagonists at presyn

• Marca: Biosynth

Propriedades químicas

• Peso molecular: 265.35 g/mol
• Fórmula: C₁₇H₁₉N₃
• Pureza: Min. 95%